A detailed history of Delphi Management Inc /Ma/ transactions in Incyte Corp stock. As of the latest transaction made, Delphi Management Inc /Ma/ holds 1,200 shares of INCY stock, worth $98,808. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,200
Holding current value
$98,808
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 23, 2024

BUY
$51.18 - $63.75 $61,416 - $76,500
1,200 New
1,200 $73,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Delphi Management Inc /Ma/ Portfolio

Follow Delphi Management Inc /Ma/ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delphi Management Inc /Ma/, based on Form 13F filings with the SEC.

News

Stay updated on Delphi Management Inc /Ma/ with notifications on news.